drugset / Trial / NCT00618709
Dose-Escalation Safety and Pharmacokinetic Study of ATX-101
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this research is to evaluate the safety and pharmacokinetic profile of single doses of ATX-101
Timeline
- Start
- 2008-01
- Primary completion
- 2008-12
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATX-101 | Peptide | 1 unknown | Subcutaneous |
| Subject | ATX-101 | Peptide | 2 unknown | Subcutaneous |
| Subject | ATX-101 | Peptide | 4 unknown | Subcutaneous |
| Subject | ATX-101 | Peptide | 8 unknown | Subcutaneous |
Indications
No indication recorded.